abstract |
The invention relates to a new subpopulation of CD8 + CD45RC low Tregs, namely IFNγ + IL-10 + IL-34 + secreting population of CD8 + CD45RC low Treg cells, methods for their isolation and expansion and their use as drug, more particularly for immunotherapy as well as biomarker. |